2007

1. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: Influence on the severity of psychotic symptoms and on the response to neuroleptic treatment

   Pharmacogenomics Journal, Vol. 7, Núm. 6, pp. 418-426